Delayed onset phlegmasia cerulea dolens post-SARS-CoV-2 infection treated with minimally invasive clot retrieval technology

Delayed onset phlegmasia cerulea dolens post-SARS-CoV-2 infection treated with minimally invasive clot retrieval technology

Coronavirus disease 2019 is associated with a significant venous thromboembolic risk. Phlegmasia cerulean dolens is a severe form of deep vein thrombosis that can lead to acute limb ischemia. In this report, we present a 58-year-old woman who developed a delayed-onset left lower extremity phlegmasia...

Full description

Bibliographic Details
Main Authors: Michael Carey, MSc, Osaid Alser, MD, MSc(Oxon), Jessica Leist, MMS, PA-C, Kelsee Sorrells, RN, BSN, CCRN, Brittany K. Bankhead, MD, MS, FACS, Wei Li, MD, MPH, MJ, RPVI, RVT, FACS
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Journal of Vascular Surgery Cases and Innovative Techniques
Subjects:
COVID-19
Phlegmasia cerulean dolens
minimally invasive percutaneous mechanical thrombectomy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468428722002313

Internet

http://www.sciencedirect.com/science/article/pii/S2468428722002313

Similar Items